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Upon DNA damage, eukaryotic cells activate a conserved signal transduction cascade known as the DNA
damage checkpoint (DDC). We investigated the influence of DDC kinases on nucleotide excision repair (NER)
in Saccharomyces cerevisiae and found that repair of both strands of an active gene is affected by Mec1 but not
by the downstream checkpoint kinases, Rad53 and Chk1. Repair of the nontranscribed strand (by global
genome repair) requires new protein synthesis, possibly reflecting the involvement of Mec1 in the activation of
repair genes. In contrast, repair of the transcribed strand by transcription-coupled NER (TC-NER) occurs in
the absence of new protein synthesis, and DNA damage results in Mec1-dependent but Rad53-, Chk1-, Tel1-,
and Dun1-independent phosphorylation of the TC-NER factor Rad26, a member of the Swi/Snf group of
ATP-dependent translocases and yeast homologue of Cockayne syndrome B. Mutation of the Rad26 phosphor-
ylation site results in a decrease in the rate of TC-NER, pointing to direct activation of Rad26 by Mec1 kinase.
These findings establish a direct role for Mec1 kinase in transcription-coupled repair, at least partly via
phosphorylation of Rad26, the main transcription-repair coupling factor.
The genomes of living cells are constantly challenged by a
variety of endogenous and exogenous agents capable of dam-
aging DNA. In order to maintain genomic stability, elaborate
pathways to repair DNA damage have evolved (22, 42). The
most versatile of these is nucleotide excision repair (NER),
which deals with a variety of helix-distorting lesions, including
UV light-induced cyclobutane-pyrimidine dimers (CPDs) and
those caused by the UV-mimetic 4-nitroquinoline-1-oxide
(4NQO), as well as other bulky chemical adducts and various
inter- and intrastrand cross-links (41, 60). The importance of
NER is exemplified by the existence of various human syn-
dromes that are linked to defects in this repair pathway, in-
cluding xeroderma pigmentosum (XP), Cockayne syndrome
(CS), and trichothiodystrophy (TTD) (10).
NER is a multistep process comprising lesion detection,
helix opening, the formation of dual incisions around the
site of damage, and, lastly, repair synthesis. The core reac-
tion, involving more than 30 proteins, can be reconstituted
in vitro using purified components from both humans (1, 35)
and Saccharomyces cerevisiae (18). Two subpathways of
NER exist: transcription-blocking lesions in the transcribed
strand (TS) of active genes are repaired quickly by transcrip-
tion-coupled NER (TC-NER), whereas the rest of the ge-
nome, including the nontranscribed strand (NTS) of active
genes, is repaired more slowly by global genome NER (GG-
NER) (8, 33, 34, 44, 54).
Damage detection in TC-NER is carried out by elongating
RNA polymerase II (RNAPII) itself (reviewed in reference
50). When RNAPII stalls at a lesion in the TS of a gene, it
somehow recruits a transcription-repair coupling factor that
initiates NER. In humans, the best-understood TC-NER factor
is the Cockayne syndrome B protein (CSB) (56). Mutations in
CSB give rise to CS, a severe disease characterized by sensi-
tivity to sunlight, neurological degeneration, growth defects,
skeletal abnormalities, and mental retardation (10). The exact
mechanism of eukaryotic TC-NER and the basis of most CS
phenotypes remain unclear (36).
The Saccharomyces cerevisiae homologue of CSB, Rad26,
was cloned based on sequence similarity and is required for
normal TC-NER (58). However, in contrast to mammalian
cells lacking CSB, yeast cells lacking RAD26 are not UV sen-
sitive. In addition, budding yeast has a second TC-NER path-
way, which is dependent on Rpb9, a nonessential subunit of
RNAPII (29). The reason that rad26 cells are not UV sensi-
tive is almost certainly that yeast cells can remove DNA dam-
age also in the transcribed strand rather efficiently by GG-
NER, a pathway requiring the RAD7 and RAD16 gene
products. Indeed, cells lacking one of these GG-NER genes as
well as RAD26 are much more UV sensitive than cells lacking
only the GG-NER gene (59).
Another process utilized by eukaryotic cells to preserve
genomic integrity in the presence of DNA damage is the com-
plex signal transduction cascade known as the DNA damage
checkpoint (DDC), which leads to temporary cell cycle arrest
(reviewed in reference 37). This increases survival by allowing
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additional time for repair and by preventing replication and
segregation of the damaged genome. Checkpoint mutants were
first isolated because of their inability to delay cell cycle pro-
gression into mitosis after gamma irradiation (61, 62). Like
many other signal transduction cascades, the DNA damage
checkpoint proteins can be subdivided into groups of proteins
acting at various steps: damage sensors, signal transducers, and
effectors. Presently, about 20 proteins have been identified as
components of the damage checkpoint (7). In Saccharomyces
cerevisiae, the most important of these is the Mec1 protein
kinase, the yeast homologue of human ATR (26, 39, 45). Mec1
controls the checkpoint by direct phosphorylation of target
proteins but also via phosphorylation of downstream effector
kinases, most notably the kinases Rad53 and Chk1 (11, 43, 49).
In addition to preventing cell cycle progression in the pres-
ence of DNA lesions, it is widely accepted, but rarely demon-
strated, that the checkpoint may also enhance the repair ca-
pacity of cells. A primary mechanism by which this is achieved
may be upregulation of genes encoding factors relevant for
repair. Indeed, approximately 5% of the yeast genome is up-
regulated in response to various DNA-damaging agents (15,
23, 24). Many of these genes are regulated by Mec1, indicating
an involvement of the DNA damage checkpoint in the DNA
damage-related transcriptional response (15).
However, little is known about whether DNA repair factors
are also directly regulated by checkpoint factors, for example
via their phosphorylation. Examples of repair proteins that are
phosphorylated by checkpoint kinases in budding yeast include
Rad55 and Nej1 (3, 21), modification of which leads to en-
hanced repair of double-strand breaks. Less is known about
direct phosphorylation of NER factors by the checkpoint ki-
nases, although a central NER protein in human cells, XPA, is
known to be phosphorylated by ATR after UV irradiation.
Such phosphorylation is required for normal levels of survival
after UV treatment. ATR also controls nuclear import of XPA
after DNA damage, but this is possibly independent of phos-
phorylation (64, 65).
In this study, we show that NER in budding yeast is severely
compromised in cells lacking the Mec1 kinase (but not in cells
lacking the downstream checkpoint kinases Rad53 and Chk1),
and we identify a novel Mec1 target, the TC-NER factor
Rad26. Loss of Mec1-catalyzed Rad26 phosphorylation de-
creases the rate of TC-NER, indicating that this modification is
required for optimal Rad26 function during DNA repair.
MATERIALS AND METHODS
Yeast strains. All the Saccharomyces cerevisiae strains used were congenic with
strain W303 (leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-1) (55) and were
grown and manipulated using standard techniques. A detailed list of the strains
used in this study can be found in Table 1. Details about N-terminal tagging of
RAD26 are available upon request.
Plasmids. The genomic MHRAD26 locus was amplified by PCR and cloned
into pRS316 (47). For galactose-inducible overexpression of MHRAD26, the
open reading frame was cloned into the pYC2 vector (Invitrogen). Site-directed
mutagenesis was carried out using the QuikChange II XL kit (Stratagene) ac-
cording to the manufacturer’s instructions, and the presence of the point muta-
tions was confirmed by sequencing. Plasmids pHAMec1wt and pHAMec1kd
were a generous gift from George S. Brush.
Yeast growth and treatment. Yeast strains were grown to early log phase (1 
107 to 2 107 cells/ml) in appropriate medium. For UV treatment, the cells were
collected by centrifugation and plated on agar plates and UV irradiation was
performed using a UV Stratalinker 2400 (Stratagene). Afterwards, the cells were
washed off the plate into the relevant prewarmed growth medium, and post-UV
incubation was carried out for the indicated times. Treatment with methyl meth-
anesulfonate (MMS; 99% stock solution; Sigma), bleomycin (5-mg/ml stock
solution in water), H2O2 (1 M stock solution in water), and 4NQO (10-mg/ml
stock solution in dimethyl sulfoxide [DMSO]) was performed by adding the
compounds directly to the medium.
SDS-PAGE, Western blotting, and antibodies. Fast preparation of yeast pro-
tein extracts was carried out as described previously (28). For detection of Rad26
phosphorylation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed using Criterion XT 3 to 8% gradient precast gels
(Bio-Rad), run until the 100-kDa marker reached the bottom of the gel. Western
blotting was carried out using standard techniques. Myc-tagged Rad26 was de-
tected using monoclonal 9E10 antibody (12), and hemagglutinin (HA)-tagged
Mec1 was detected using polyclonal anti-HA antibody (Abcam).
Galactose-induced protein overexpression. Yeast cells were grown in medium
containing raffinose to a cell density of 5  106 cells/ml. Galactose was added to
a final concentration of 2%, and incubation continued for 3 h. 4NQO was added
at a concentration of 5 g/ml for purification of phosphorylated Rad26. For
repression of HA-Mec1 expression, 2% glucose was added to the medium in-
stead of galactose.
MS. Polyacrylamide gel slices (1 to 2 mm) containing Rad26 were prepared for
mass spectrometric (MS) analysis using the Janus liquid handling system (Perkin-
Elmer). Briefly, the excised protein gel piece was placed in a well of a 96-well
microtiter plate and destained with 50% (vol/vol) acetonitrile and 50 mM am-
monium bicarbonate, reduced with 10 mM dithiothreitol (DTT), and alkylated
TABLE 1. – Saccharomyces cerevisiae strains used in this study
Strain Genotype Referenceor source
W303 1A MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100
W303 1B MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100
MGSC102 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 rad26::HIS3 58
MGSC126 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 rad16::LEU2 59
MGSC107 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 rad16::LEU2 rad26::HIS3 59
JSY1105 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 URA3::MHRAD26 This study
JSY1106 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 URA3::MHRAD26 rad16::LEU2 This study
JSY1107 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 rad16::LEU2 rpb9::TRP1 This study
JSY1108 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 rad16::LEU2 rpb9::TRP1 rad26::HIS3 This study
JSY1109 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 URA3::MHRAD26 mec1::HIS3 sml1::TRP1 This study
JSY1110 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 URA3::MHRAD26 chk1::HIS3 This study
JSY1111 MAT leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 URA3::MHRAD26 rad53::HIS3 sml1::TRP1 This study
JSY1112 MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 mec1::HIS3 sml1::TRP1 This study
JSY1113 MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 chk1::HIS3 This study
JSY1114 MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 rad53::HIS3 sml1::TRP1 This study
JSY1115 MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 mec1::HIS3 sml1::TRP1 rad26::KanMx This study
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with 55 mM iodoacetamide. After alkylation, Rad26 was digested with 6 ng/l
trypsin (Promega) overnight (o/n) at 37°C. The resulting peptides were extracted
in 1% (vol/vol) formic acid, 2% (vol/vol) acetonitrile. The digest was analyzed by
nanoscale capillary liquid chromatography-tandem MS (LC-MS/MS) using a
nanoAcquity ultraperformance liquid chromatograph (UPLC; Waters) to deliver
a flow of approximately 300 nl/min. A C18 Symmetry 5-m, 180-m by 20-mm
-Precolumn (Waters) trapped the peptides prior to separation on a C18
BEH130 1.7-m, 75-m by 100-mm analytical UPLC column (Waters). Peptides
were eluted with a gradient of acetonitrile. The analytical column outlet was
directly interfaced via a modified nanoflow electrospray ionization source, with a
two-dimensional (2-D) linear ion trap mass spectrometer (LTQ XL/ETD; Thermo-
Scientific), equipped with a chemical ionization source to enable the generation
and injection of fluoranthene radical anions for the electron transfer dissociation
(ETD) reaction (9). The ETD process uses ion/ion chemistry to provide se-
quence information not available through conventional methods such as colli-
sion-induced dissociation (CID). Peptide fragmentation using an ETD approach
augments the current methodologies available for the characterization of post-
translational modifications by more accurately identifying the specific amino
acids that are modified. Data-dependent analysis was carried out in either CID
or ETD mode, where automatic MS/MS spectra were acquired on multiply
charged precursor ions in the m/z range 300 to 2,000. As predominantly doubly
protonated ions are generated by tryptic digestion, a supplemental activation
energy was used to improve fragmentation in the ETD experiments (51). All
LC-MS/MS data were then searched against a protein database (UniProt 13.6)
using the Mascot search engine program (Matrix Science, United Kingdom),
with oxidized methionine, carbamidomethyl cysteine and phosphoserine, threo-
nine, and tyrosine included as variable modifications (40).
Preparation of yeast extracts and immunoprecipitation of Rad26. Cell pellets
were resuspended in yeast lysis buffer (150 mM Tris-acetate, pH 7.8, 20%
glycerol, 50 mM potassium acetate, 3 mM EDTA, 5 mM DTT, 0.1% Triton
X-100, 1 protease inhibitors) (38). Silica beads were added, and cells were
disrupted using a FastPrep-24 tissue and cell homogenizer (MP Biomedicals).
Immunoprecipitation was carried out overnight at 4°C using protein A-coated
beads coupled to 9E10 antibody. Beads were washed 3 times consecutively with
lysis buffer containing 500 mM potassium acetate, followed by 2 washes with
tobacco etch virus (TEV) cleavage buffer (10 mM Tris-HCl, pH 8, 150 mM NaCl,
1 mM -mercaptoethanol). TEV elution was performed by resuspending the
beads in 50 l of TEV elution buffer and adding 3 g of TEV protease for 6 h
at 4°C. The supernatant containing the eluted protein was harvested after cen-
trifugation.
Strand-specific nucleotide excision repair analysis. NER assays were carried
out as described previously (52, 53) with minor modifications. Cells were grown
to a cell density of 4  107 cells/ml in 400 ml of appropriate medium, harvested
by centrifugation, and resuspended in 800 ml ice-cold phosphate-buffered saline
(PBS; cell density, 2  107 cells/ml). This cell suspension was irradiated with 100
J/m2 UV-C light using a germicidal lamp. After treatment, the cells were again
collected by centrifugation, resuspended in fresh medium, and allowed to recover
at 30°C in the dark. Aliquots were removed either before UV irradiation (U),
immediately after UV irradiation (0), or at the indicated time points after UV
treatment (usually up to 4 h). The cell pellets were resuspended in 5 ml sphero-
blasting buffer (0.9 M sorbitol, 100 mM Tris-HCl, pH 8.0, 100 mM EDTA, 28
mM -mercaptoethanol, 5 mg Zymolyase 20 T) and incubated o/n at 4°C in the
dark. The resulting spheroblasts were lysed by resuspension in lysis buffer (2 M
urea, 100 mM NaCl, 50 mM Tris-HCl, pH 8.0, 5 mM CDTA, 0.25% [wt/vol]
n-lauroyl sarcosine), and the genomic DNA was isolated and purified using
phenol-chloroform extraction and ethanol precipitation. The DNA was resus-
pended in Tris-EDTA (TE) to a final concentration of about 0.5 mg/ml. Fifty
micrograms of genomic DNA for each time point was then digested with HaeIII.
After purification of digested DNA, the samples were incubated with protein
extract from Micrococcus luteus in order to achieve incision at CPDs (details
available upon request), and the DNA was again purified and resuspended in 100
l TE. Analysis of a HaeIII restriction fragment of the RPB2 gene was achieved
using biotinylated probes for either the TS (5-biotin-GATAGCTTTTTTCCGT
TTACCGATTATGTTAAGATCAAAGAA-3) or the NTS (5-biotin-GATAG
CTTTTTTCCAATAATGGACCTGCCAAATCTAATCT-3). Hybridization of
the probes (1 l of 2 mM stock) was carried out in the presence of 1 M NaCl. The
mixture of DNA and probe was heated to 95°C for 5 min and then incubated at
55°C for 15 min. Streptavidin-coated magnetic beads were added for 10 min, and
then the mixture was washed with BW buffer (1 M NaCl, 5 mM Tris-HCl, pH 8.0,
0.5 mM EDTA). The beads were finally resuspended in 4 l of water, and
labeling was carried out using the Sequenase v2.0 kit (USB) according to the
manufacturer’s instructions. After the beads were washed several times in water,
the labeled fragments were eluted with formamide loading buffer and separated
on a 6% denaturing gel.
Quantification of damage half-lives (time required to remove 50% of the
damages [t50%]). Damage signals (total signal without signal for the undamaged
band at the top of the gel) were determined using a phosphorimager and then
normalized for the total signal in the respective lanes to correct for differences in
loading. The nonspecific signals detected in the unirradiated lane (background)
were subtracted from lanes displaying samples with damaged DNA. The signal
obtained for time zero was set to 1, and the signals for the later time points were
set in relation to that. A graph with a trend line was made using Microsoft Excel
software, and the time point at which the trend line crossed the 0.5 value was
determined empirically.
RESULTS
NER is compromised in checkpoint-deficient cells. In order
to investigate if, and to what extent, the central checkpoint
kinase Mec1 affects NER in yeast, we measured the kinetics of
CPD removal in a 740-bp fragment of the yeast RPB2 gene in
a mec1 sml1 double mutant strain (deletion of SML1 is
necessary to suppress the lethality of MEC1 deletion [66]),
using a method which allows analysis of strand-specific repair
at nucleotide resolution (52, 53). The repair rate in the check-
point-deficient mutant was compared with that of the wild-type
strain (W303; WT) and the TC-NER-deficient rad26 mutant.
A representative gel is shown in Fig. 1A. The signals for the
individual lanes were quantified using a phosphorimager, and
the t50% was calculated for the individual strains (Fig. 1B). As
expected, the difference in repair kinetics between the prefer-
entially repaired TS and the NTS was evident in the WT strain,
while no clear strand specificity was observed in TC-NER-
deficient rad26 cells. Interestingly, cells lacking the check-
point kinase Mec1 exhibited a dramatic impairment of NER,
characterized by markedly slower repair of the TS and virtually
no repair of the NTS at 4 h post-UV irradiation. A main role
of Mec1 is to activate downstream checkpoint kinases, such as
Rad53 and Chk1 (14). Interestingly, however, no NER defects
were observed in the chk1 and rad53 sml1 strains (Fig. 1B
and data not shown). Together, these results indicate that a
normal DNA damage checkpoint, and more specifically the
Mec1 kinase, is required for efficient repair by both NER
subpathways.
Damage-induced de novo protein synthesis is necessary for
GG-NER but not TC-NER. The DNA damage checkpoint me-
diates transcriptional induction of many genes involved in a
variety of cellular processes, including DNA repair (2, 15).
Previous studies have shown that UV-induced de novo synthe-
sis of proteins is required for repair of the NTS, but not the TS,
of the active GAL10 and URA3 genes (5). In order to deter-
mine whether this is also the case for the RPB2 gene, we
carried out NER assays on wild-type yeast treated with cyclo-
heximide (CHX) (in order to abolish synthesis of new proteins)
1 h before UV treatment. Repair of the TS was not detectably
affected by CHX treatment, while severely defective NTS re-
pair was observed, similar to that observed in the mec1 sml1
strain (Fig. 1C). Together, these results are consistent with the
idea that the defect in GG-NER observed in the checkpoint-
deficient strain is due to defects in induced expression of fac-
tors required for dealing with DNA damage, while the defect
in TC-NER must be caused by a preexisting factor(s).
Rad26 is phosphorylated after DNA damage. One possible
explanation for the decrease in TC-NER in the mec1 sml1
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strain is that a checkpoint kinase is phosphorylating a tran-
scription-repair coupling factor to allow efficient damage re-
moval in the TS. Since Rad26 is the best-characterized TC-
NER protein in yeast, it was a primary candidate for
investigation. We therefore generated a strain expressing
Rad26, tagged N-terminally with 9 Myc epitopes and 8 histi-
dine residues separated by 2 TEV cleavage sites (16), from its
endogenous promoter within the genome (MHRAD26). Ge-
netic characterization of the strain indicated that this protein is
fully functional in TC-NER (data not shown). MHRAD26 cells
were irradiated with UV-C light, and the SDS-PAGE mobility
of tagged Rad26 was analyzed using an anti-Myc antibody.
Interestingly, a slower-migrating form of the Rad26 protein
became evident just 10 min after UV treatment, peaked be-
tween 1 and 2 h, and started disappearing thereafter (Fig.
2A). A longer exposure of the Western blots revealed that
even in the absence of UV damage the mobility of a small
amount of Rad26 was shifted (data not shown). To deter-
mine if phosphorylation of Rad26 was responsible for the
observed shift in electrophoretic mobility, we immunopre-
FIG. 1. Normal NER requires MEC1. (A) Representative sequencing gel showing a comparison of strand-specific repair in W303 (wild type),
rad26 (TC-NER-deficient), and mec1 sml1 (checkpoint-deficient) cells. Numbers on the left and on the right of the gel indicate the nucleotide
position relative to the RPB2 transcription start site on the TS and NTS, respectively. A nonspecific band appearing also in the unirradiated control
sample (U) is marked with an asterisk. (B) Quantification of the signals from sequencing gels such as the one shown in panel A. Damages
remaining at the different time points post-UV irradiation were calculated, and the time necessary for removal of 50% of the damages (t50%) was
determined for both the TS and the NTS. Error bars show the standard error (2 independent experiments). (C) Quantification of NER in wild-type
cells that were either left untreated (CHX) or treated with 50 g/ml cycloheximide (CHX) for 1 h before UV treatment. Damage half-lives
(t50%) are shown for the TS and the NTS, with error bars indicating the standard error (2 independent experiments).
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cipitated Rad26 and treated the bead-bound material with
shrimp alkaline phosphatase (SAP) to reverse phosphoryla-
tion. The slower-migrating protein was lost after incubation
with phosphatase, indicating that it represents a phosphory-
lated form of Rad26 (Fig. 2B).
Rad26 is phosphorylated by the Mec1 kinase. To investigate
whether Rad26 phosphorylation occurred specifically in re-
sponse to UV irradiation or if it also occurs following other
types of DNA damage, we now treated cells with various chem-
ical agents to induce different types of DNA lesions. All of
these DNA damage-inducing treatments caused Rad26 to be
phosphorylated (Fig. 2C). Interestingly, other forms of cellular
stress, including heat shock and osmotic shock, did not result in
such modification (Fig. 2D). Because Rad26 is known to be
recruited to stalled RNA polymerase II complexes and because
UV-induced DNA lesions cause RNAPII stalling, we also
tested whether 6-azauracil (6AU) could mediate Rad26 phos-
phorylation (6AU causes frequent RNAPII stalling by restrict-
ing nucleotide availability). However, treatment with 6AU did
not cause a detectable increase in the phosphorylated form of
Rad26 (Fig. 2D), suggesting that Rad26 modification is not a
result of RNAPII stalling but rather represents a response to
DNA damage. Finally, because we had observed that CHX
addition affected GG-NER but not TC-NER, we also investi-
gated the effect of CHX on Rad26 phosphorylation after DNA
damage. CHX addition did not affect Rad26 phosphorylation
(Fig. 2E).
To determine whether a functional DNA damage check-
point is required for Rad26 phosphorylation, we tested
whether the modification occurs in the mec1 sml1 strain.
Interestingly, it did not (Fig. 3A). To confirm that the lack of
phosphorylation was due to the absence of Mec1 kinase activ-
ity and not an indirect result of concomitant MEC1 and SML1
deletion, we reintroduced galactose-inducible forms of HA-
tagged wild-type MEC1 (MEC1wt) or kinase-dead MEC1
(MEC1kd) into these cells. Rad26 phosphorylation was recov-
ered by growing cells carrying MEC1wt in galactose, but not
glucose, while MEC1kd was unable to generate modified Rad26
despite being expressed at a level similar to the wild-type
protein (Fig. 3B, compare lanes 3 and 4 with lanes 7 and 8).
This indicates that the kinase activity of Mec1 is required for
Rad26 phosphorylation.
As shown above, Mec1, but not its downstream signal trans-
ducers, Chk1 and Rad53, is required for normal TC-NER. To
determine if Chk1 or Rad53 (either directly or indirectly) is
required for phosphorylation of Rad26, we deleted CHK1 or
RAD53 and examined the phosphorylation state of Rad26 in
these cells after UV irradiation. Moreover, we also tested the
effect of deletion of TEL1 (encoding the yeast homologue of
the ATM kinase) and DUN1 (encoding a kinase acting down-
stream of Rad53 in the DNA damage checkpoint pathway) on
Rad26 phosphorylation. Damage-induced phosphorylation
was abrogated only in cells lacking the Mec1 kinase, supporting
the idea that Mec1 directly phosphorylates Rad26 without the
involvement of downstream kinases (Fig. 3C). This result is
also in agreement with the observation that MEC1 deletion,
but not CHK1 or RAD53 deletion, leads to a defect in TC-NER
(Fig. 1B).
Rad26 is phosphorylated primarily on serine 27. Mec1
phosphorylates serine and threonine residues that are imme-
diately adjacent to a glutamine (SQ/TQ motifs) (14). Rad26
possesses 1 TQ and 4 SQ consensus motifs (Fig. 4A). We
cloned the MHRAD26 locus into the pRS316 vector (47), mu-
tated these sites individually to alanine, and then analyzed the
phosphorylation status of Rad26 after treatment with the UV-
mimetic compound 4NQO (Fig. 4B). 4NQO was used in place
of UV treatment because this drug can be used in a more easily
controlled manner and because it also leads to posttransla-
tional modification of Rad26 (Fig. 2C). The different versions
of the Rad26 protein were expressed at similar levels (compare
lanes 1, 3, 5, 7, 9, and 11). Mutation of Rad26 serine 27
abolished the 4NQO-induced shift, whereas all the other single
point mutants behaved like the wild-type protein (Fig. 4B,
compare lane 4 with lanes 2, 6, 8, 10, and 12, respectively),
suggesting that S27 is the only phosphorylated residue in
Rad26. However, we could not rule out the possibility that a
residual modification escapes detection by SDS-PAGE mobil-
ity shift. We therefore also utilized MS to investigate sites of
Rad26 phosphorylation. Due to the low abundance of Rad26,
we were unable to purify enough modified protein for MS
FIG. 2. Damage-induced phosphorylation of Rad26. (A) Western blot analysis of Rad26 from wild-type cells harvested either before (0) or at
various time points after UV irradiation. (B) Western blot analysis of Rad26 immunoprecipitated before and 2 h after UV treatment and treated
either with buffer alone or with shrimp alkaline phosphatase. (C) Western blot analysis of Rad26 from undamaged cells and from cells treated with
the indicated doses of various DNA-damaging agents for 1 h. (D) Western blot analysis of Rad26 from untreated wild-type cells or from cells
treated with heat shock (shift from 30°C to 42°C), osmotic shock (addition of 600 mM NaCl to the medium), or 6AU (addition of 200 g/ml to
the medium) for 1 h. (E) Western blot analysis of Rad26 after UV treatment in the presence of the translation inhibitor cycloheximide.
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analysis. To try to circumvent this problem, the tagged gene
was placed behind a galactose-inducible promoter on a cen-
tromeric plasmid (pYC2-MHRAD26) and introduced into a
rad26 mutant. Expression was induced by growth in galac-
tose-containing medium, after which cellular DNA was dam-
aged by treatment with 4NQO. Rad26 was purified using Myc
affinity resin and eluted using TEV protease. Interestingly, the
availability of more protein made it possible to visualize two
slower-migrating forms of Rad26 after extended SDS-PAGE
and staining of the gel (Fig. 4C), suggesting that more than one
phosphate group can be added to Rad26 after DNA damage.
Indeed, MS analysis indicated that both S27 and S30 were
phosphorylated in this sample. These sites of phosphorylation
were identified following peptide fragmentation using both
CID and ETD. Moreover, while this work was in progress, a
proteome-wide study of protein phosphorylation reported that
S27 and S29 of Rad26 are phosphorylated in a Mec1-depen-
dent manner (4). Surprisingly, neither S29 nor S30 exists in the
context of a proper Mec1 consensus motif (Fig. 4A). We there-
fore speculated that S27 is the primary Rad26 phosphorylation
site but that serine residues nearby might become targeted as
“innocent bystanders” in connection with S27 phosphorylation.
In order to investigate this idea, we mutated S27 in the pYC2-
MHRAD26 plasmid (creating plasmid pYC2-MHRAD26S27A)
and analyzed both the wild-type and the mutant protein after
4NQO treatment. Indeed, whereas the wild-type protein
showed 2 distinct slower-migrating bands, no shift was ob-
served with the S27A mutant (Fig. 4D). The absence of phos-
phorylated residues in this mutant was also confirmed by mass
spectrometry. Together, these data indicate that Mec1 phos-
phorylates S27 of Rad26 after DNA damage and that this
event may also occasionally result in modification of S29
and/or S30 as well.
Rad26 phosphorylation enhances TC-NER efficiency. Given
that MEC1 deletion affects NER and that Rad26 appears to be
a direct target of the Mec1 kinase, we asked whether Rad26
phosphorylation plays a role in TC-NER. We first tried to test
this genetically, taking advantage of the fact that the rad16
rad26 double mutant is much more UV sensitive than either
single mutant (59). Point mutants in which Rad26 serine 27
was mutated either to alanine to prevent phosphorylation
(rad26SA) or to glutamic acid to mimic phosphorylation
(rad26SE) were introduced into rad16 rad26 cells, and the
UV sensitivity of these strains relative to control strains was
tested by spotting assays. However, like wild-type Rad26, both
mutated forms of Rad26 rescued the rad16 rad26 double
mutant so that its UV sensitivity was similar to that of the
rad16 single mutant (data not shown). Simultaneous muta-
tion of all five Mec1 consensus target motifs (SQ/TQ), or
concomitant mutation of serines 27, 29 and 30, also did not
lead to increased UV sensitivity (data not shown). In order to
exclude the possibility that the effect of the point mutations in
Rad26 is masked by the second TC-NER pathway in yeast,
which is mediated by the Rpb9 protein (29), we also carried out
the same assay using a rad16 rad26 rpb9 triple mutant.
Again, we failed to detect a defect in the phosphorylation
mutants that could be uncovered by this assay (data not
shown).
These results indicate that phosphorylation of Rad26 is not
absolutely required for the function of the protein in repair but
did not rule out the possibility that the modification has an
effect on TC-NER kinetics that is not severe enough to cause
altered sensitivity to UV light in phenotypic assays. In order to
investigate TC-NER and GG-NER directly, we again utilized
the strand-specific NER assay. rad26 mutants carrying wild-
type RAD26 (RAD26WT) were compared to those carrying no
RAD26, rad26SA, or rad26SE. Figure 5A and B shows that, as
expected, severely delayed TC-NER was observed in cells lack-
ing RAD26 compared to the wild-type control. Importantly,
although the effect was less pronounced than that observed in
rad26 cells, cells expressing the Rad26 alanine mutant exhib-
ited a clear and highly reproducible delay in TC-NER (Fig. 5A,
FIG. 3. The DNA damage checkpoint kinase Mec1 is required for
Rad26 phosphorylation. (A) Western blot analysis of Rad26 phosphor-
ylation before and after UV irradiation in wild-type and checkpoint-
deficient mec1 sml1 cells. (B) Western blot analysis of Rad26 phos-
phorylation in mec1 sml1 cells carrying expression plasmids for
HA-tagged wild-type or kinase-dead Mec1. Extracts were prepared
from cells in which expression of Mec1 was either induced with galac-
tose (Gal) or repressed with glucose (Glu), before and 1 h after UV
irradiation. Mec1 and Rad26 proteins were detected using antibodies
against HA and Myc epitopes, respectively. (C) Western blot analysis
of Rad26 phosphorylation before and after UV irradiation in cells of
the indicated genotype.
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rad26SA), so that damage half-life was extended from 	1.7 h in
the presence of wild-type RAD26 to 	2.6 h in the rad26SA
mutant, while damage half-life in rad26 cells was 
3.5 h (Fig.
5B). TC-NER in the rad26SE mutant (where glutamate mimics
persistent phosphorylation) was largely unaffected (Fig. 5A
and B). Repair of the NTS was not affected by any of the
mutations. Together, these results indicate that damage-in-
duced phosphorylation of Rad26 by the Mec1 kinase enhances
the rate of TC-NER.
Expression of the rad26SE mutant is not sufficient to rescue
the TC-NER defects of a mec1 sml1 mutant. The finding
that the Rad26 phosphomimic mutation does not significantly
affect TC-NER kinetics in the wild-type background led us to
investigate whether introducing this mutant into the mec1
sml1 background could bypass the requirement for the Mec1
kinase for efficient TC-NER, i.e., whether Rad26 is the only
important Mec1 target in this process. We therefore deleted
RAD26 in the mec1 sml1 strain and reintroduced RAD26WT,
rad26SA, rad26SE, or the empty vector as control. Analysis of
TC-NER kinetics in these strains showed that the remaining
TC-NER in the mec1 sml1 cells is highly dependent on the
presence of Rad26 (Fig. 5C). Reintroduction of either
RAD26WT or rad26SA brought the rate of TC-NER back to the
level of the mec1 sml1 strain, showing that, as expected,
mutating the phosphorylation site in Rad26 to alanine does not
further diminish TC-NER if the strain already lacks the re-
sponsible Mec1 kinase. Mutation of Rad26 S27 to a glutamic
acid residue did not lead to faster TC-NER in the checkpoint-
deficient strain, showing that expression of a phosphorylation-
mimicking mutant of Rad26 is not sufficient to bypass the
requirement for Mec1 (Fig. 5C). Because of the severe inhibi-
tion of TC-NER in the mec1 sml1 rad26 strain (compared
to the mec1 sml1 strain), it might be expected that this
mutant would be considerably more UV sensitive than the
mec1 sml1 strain. Surprisingly, however, this was not the
case (Fig. 5D). As a matter of fact, RAD26 deletion had little
effect or appeared to slightly suppress the UV sensitivity of the
mec1 sml1 strain at high UV doses. This result indicates that
cellular characteristics other than the rate of TC-NER repair
are important for cell survival after UV irradiation and rein-
forces the idea that slower kinetics of TC-NER do not neces-
sarily result in increased sensitivity to UV irradiation, as ob-
served previously with the rad26SA mutant.
DISCUSSION
In this study we investigated the interplay between the DNA
damage checkpoint and NER by examining the efficiency of
DNA repair in cells lacking checkpoint kinases. Our data in-
dicate that repair of both strands of an active gene is defective
in cells lacking Mec1 but not in cells lacking Rad53 and Chk1,
indicating that the DDC—and specifically Mec1—affects both
TC-NER and GG-NER.
Although we did not investigate it in detail, the role of the
FIG. 4. Identification of serine 27 as the Rad26 phosphorylation site. (A) Schematic representation of the SQ/TQ motifs in the Rad26 protein.
Gray boxes show the positions of the nuclear localization signal (NLS) and the 7 conserved SWI2/SNF2 translocase domains. (B) Western blot
analysis of Rad26 phosphorylation before and after 4NQO treatment (5 g/ml) in rad26 cells carrying a plasmid for expression of either wild-type
Rad26 or mutant versions lacking one of the five SQ/TQ phosphorylation sites. (C) Sypro Ruby-stained gel showing wild-type Rad26 purified after
overexpression in rad26 cells either without () or with () treatment with 4NQO (5 g/ml for 10 min). (D) Sypro Ruby-stained gel showing
wild-type and S27A Rad26 purified after overexpression in rad26 cells after 4NQO treatment (5 g/ml for 10 min).
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DNA damage checkpoint in GG-NER appears to rely primar-
ily on induction of repair factors, which is in agreement with
previously published work (5), though we cannot rule out that
impairment of checkpoint activation by cycloheximide treat-
ment is partly responsible for the observed effect. The targets
of the checkpoint that are responsible for this effect are not yet
known, but potential candidates include the NER factors
Rad2, Rad7, Rad16, and Rad23 (6, 25, 31, 46). In contrast, the
checkpoint appears to function in TC-NER primarily via mod-
ification of repair factors, since inhibition of new protein syn-
thesis via cycloheximide treatment had little or no effect on this
repair pathway. Supporting this idea, we identified Rad26 as a
target for phosphorylation upon DNA damage. Rad26 phos-
phorylation required Mec1, but not Rad53, Chk1, Tel1, or
Dun1. Several of these checkpoint kinases affect cell cycle
progression after DNA damage (14), but only Mec1 affects the
rate of TC-NER, indicating that the effect of mutating this
kinase is via decreased Rad26 phosphorylation (and possibly
decreased phosphorylation of other repair factors) rather than
of defects in cell cycle progression. Rad26 is primarily modified
on serine 27 (S27), part of an SQ motif, which is also the
general consensus recognition motif for Mec1 and Tel1 ki-
FIG. 5. S27A mutation decreases the rate of TC-NER. (A) Representative gels showing side-by-side comparisons of cells expressing wild-type
Rad26 (RAD26WT) and cells carrying either empty vector (rad26) or cells expressing Rad26 in which serine 27 was replaced with an alanine
(rad26SA) or a glutamic acid (rad26SE) residue, respectively. Only gels for the TS are shown (NTS repair was not affected). Numbers on the left
indicate the nucleotide position relative to the RPB2 transcription start site. A nonspecific band appearing also in the unirradiated control sample
(U) is marked with an asterisk. (B) Comparison of the times required for repair of 50% of the damages (t50%), obtained from quantifications of
gels such as the one in panel A. Error bars indicate the standard error (3 independent experiments). (C) Quantification of NER kinetics in the
mec1 sml1 rad26 triple mutant expressing either no Rad26 (vector), wild-type Rad26 (RAD26WT), or Rad26 in which serine 27 was replaced
with an alanine (rad26SA) or a glutamic acid (rad26SE) residue. (D) Spotting assay comparing the UV sensitivities of the wild-type strain (W303),
the mec1 sml1 double mutant, and the mec1 sml1 rad26 triple mutant.
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nases. Most importantly, mutation of this phosphorylation site
to an alanine (preventing phosphorylation), but not to a neg-
atively charged glutamic acid residue (mimicking persistent
phosphorylation), leads to a clear delay in TC-NER. This delay
is most evident shortly after DNA damage induction, which
correlates well with the rapid phosphorylation of Rad26 ob-
served in response to UV irradiation. In further support of the
conclusion that S27 is the only functionally important Mec1
phosphorylation site, the rates of TC-NER in a rad26 mutant
in which all 5 SQ/TQ sites were mutated to alanine and one in
which S27/S29/S30 were mutated together were similar to that
of the rad26S27A mutant (data not shown).
How might Mec1-catalyzed phosphorylation modify the
function of Rad26 to enhance TC-NER? Unfortunately, the
mechanism of eukaryotic TC-NER is still not completely un-
derstood, and no reconstituted biochemical assay exists in
yeast with which the activities of unmodified versus modified
Rad26 can be compared. As the Rad26 protein is a DNA-
dependent ATPase (17), we speculated that this activity might
be influenced by phosphorylation. However, our initial studies
suggest that the DNA-stimulated ATPase activity of phosphory-
lated Rad26 is not significantly different from that of the un-
modified protein in vitro (data not shown). Rad26 interacts
with Def1, a factor controlling ubiquitylation and degradation
of the largest subunit of RNAPII, Rpb1 (63). In theory, the
TC-NER defect observed for the rad26S27A mutant might thus
potentially be explained if Rad26 phosphorylation interfered
with Def1 interaction and thereby the function of this protein.
However, we failed to detect significant changes in Rpb1 ubiq-
uitylation and degradation in cells expressing Rad26 phosphor-
ylation mutants (data not shown). Another possibility is that
phosphorylation of Rad26 regulates its interaction with other
TC-NER factors. We have sought to identify proteins that
might interact differently with the modified form of Rad26.
However, in our hands, few proteins associate stably with
Rad26 so that they can be identified by MS analysis. More
work is thus necessary to determine the exact function of
Mec1-catalyzed Rad26 phosphorylation in TC-NER.
In contrast to rad26SA, the rad26SE mutation resulted in little
or no defect in TC-NER, indicating that mutation of serine 27
to glutamate indeed acts as a phosphomimic. Nevertheless,
introduction of this mutant into the mec1 sml1 strain did
not alleviate the TC-NER defect in these cells. We were some-
what surprised by this finding, as the decrease observed in
TC-NER in mec1 sml1 cells was not dramatically larger
than that observed in the rad26SA mutant. This result might
indicate a requirement for other factors regulated by Mec1.
Thus, additional phosphorylation events on one or more other
factors, carried out by one or more kinases in the DDC, appear
to also be required for efficient TC-NER. This is not surprising,
as proteomic screens have identified several substrates for
checkpoint kinases (4, 32, 48), many of which are involved in
DNA repair. The identification of the functionally relevant
target(s) is an important future goal.
Somewhat surprisingly, although rad26SA—but not
rad26SE—significantly increased the half-life of UV-induced
DNA damage in the transcribed strand, we failed to uncover
phenotypic consequences of it. We also failed to uncover a
phenotypic effect of rad26 or Rad26 phosphorylation on MMS,
bleomycin, or hydrogen peroxide sensitivity (data not shown).
This indicates that the increase in repair efficiency observed
when S27 is phosphorylated is not enough to affect viability
after DNA damage. Strikingly, even though TC-NER is virtu-
ally undetectable at the RPB2 gene after deletion of RAD26 in
the mec1 sml1 strain, no significant increase in UV sensi-
tivity was observed in the mec1 sml1 rad26 strain, showing
that a decrease in TC-NER kinetics does not necessarily lead
to a an increase in UV sensitivity. This helps explain the lack of
a clear phenotypic consequence of rad26S27A mutation: other
characteristics than rate of DNA repair must be of greater
importance once a certain level of repair impairment has been
reached. Identifying other cellular processes and mechanisms
that determine UV sensitivity represents an important future
challenge.
Interestingly, TC-NER seems to play a more central role in
the response of higher cells to UV irradiation. For example,
mammalian cells lacking CSB are UV sensitive (56), while
yeast cells lacking RAD26 are not (58). The involvement of the
checkpoint in NER described here might well be conserved in
evolution and could potentially be more important for the
overall human DNA damage response. Indeed, we note that
CSB has numerous potential SQ/TQ motifs and that one of
these was recently identified as a target for ATM/ATR (32).
We found that mutation of the CSB site identified by mass
spectrometric analysis does not result in UV sensitivity in hu-
man cell lines (data not shown), but other preliminary data
suggest that more sites in CSB may also be phosphorylated, so
a more comprehensive analysis of checkpoint kinase-mediated
CSB phosphorylation will be required before firm conclusions
can be made.
Interestingly, some of the clinical features of patients suffer-
ing from Seckel syndrome (which involves deficiencies in the
DNA damage checkpoint [27]) and Cockayne syndrome are
overlapping, with both diseases resulting in microencephaly,
“birdlike” facial features, and severe growth defects (13, 20).
Although other possibilities cannot be ruled out, these simi-
larities are at least consistent with a link between the DNA
damage checkpoint and TC-NER also in humans. Indeed, the
reason why Seckel syndrome patients display these abnormal-
ities is presently unclear. Similarly, why CS patients display
them is also poorly understood, but it is almost certainly not
due to persistence of NER lesions in the transcribed strand of
active genes, as these lesions also persist in several classes of
XP patients (XPA, XPD, XPB, XPF, and XPG) who do not
display these severe symptoms (10). An attractive possibility is
that some of the phenotypes are caused by a defect of CS cells
in the transcription-coupled removal of oxidative lesions,
which also appear to be substrates for the base excision repair
(BER) pathway (57). An involvement of CSB in the repair of
such lesions has been proposed (reviewed in references 19 and
36) and might potentially explain the severe brain phenotypes
exhibited by CS patients, since oxygen consumption in the
brain is much higher than that of any other tissue, which in turn
results in high levels of harmful metabolic by-products, includ-
ing reactive oxygen species (ROS). Prolonged stalling of RNA-
PII at sites of DNA damage is a strong signal for apoptosis
(30), which would be particularly detrimental in the brain,
where cells cannot be replaced. An important future line of
research will therefore be to investigate the potential effect of
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checkpoint-dependent CSB phosphorylation on the repair of
DNA damage in higher cells.
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